Format
Sort by
Items per page

Send to

Choose Destination

Best matches for NRXN1 schizophrenia:

Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects. Marshall CR et al. Nat Genet. (2017)

Incomplete penetrance of NRXN1 deletions in families with schizophrenia. Todarello G et al. Schizophr Res. (2014)

Investigation of NRXN1 deletions: clinical and molecular characterization. Dabell MP et al. Am J Med Genet A. (2013)

Search results

Items: 1 to 20 of 95

1.

Leveraging genome-wide association and clinical data in revealing schizophrenia subgroups.

Yin L, Cheung EF, Chen RY, Wong EH, Sham PC, So HC.

J Psychiatr Res. 2018 Nov;106:106-117. doi: 10.1016/j.jpsychires.2018.09.010. Epub 2018 Sep 22.

PMID:
30312963
2.

Can Animal Models of Copy Number Variants That Predispose to Schizophrenia Elucidate Underlying Biology?

Forsingdal A, Jørgensen TN, Olsen L, Werge T, Didriksen M, Nielsen J.

Biol Psychiatry. 2019 Jan 1;85(1):13-24. doi: 10.1016/j.biopsych.2018.07.004. Epub 2018 Jul 12. Review.

PMID:
30144930
3.

A rare exonic NRXN3 deletion segregating with neurodevelopmental and neuropsychiatric conditions in a three-generation Chinese family.

Yuan H, Wang Q, Liu Y, Yang W, He Y, Gusella JF, Song J, Shen Y.

Am J Med Genet B Neuropsychiatr Genet. 2018 Sep;177(6):589-595. doi: 10.1002/ajmg.b.32673. Epub 2018 Aug 4.

PMID:
30076746
4.

NRXN1 deletion syndrome; phenotypic and penetrance data from 34 families.

Al Shehhi M, Forman EB, Fitzgerald JE, McInerney V, Krawczyk J, Shen S, Betts DR, Ardle LM, Gorman KM, King MD, Green A, Gallagher L, Lynch SA.

Eur J Med Genet. 2018 Jul 18. pii: S1769-7212(18)30079-X. doi: 10.1016/j.ejmg.2018.07.015. [Epub ahead of print]

PMID:
30031152
5.

Mini-review: Update on the genetics of schizophrenia.

Coelewij L, Curtis D.

Ann Hum Genet. 2018 Sep;82(5):239-243. doi: 10.1111/ahg.12259. Epub 2018 Jun 20. Review.

PMID:
29923609
6.

Neurexins and neuropsychiatric disorders.

Kasem E, Kurihara T, Tabuchi K.

Neurosci Res. 2018 Feb;127:53-60. doi: 10.1016/j.neures.2017.10.012. Epub 2017 Dec 6. Review.

PMID:
29221905
7.

High resolution chromosomal microarray analysis in paediatric obsessive-compulsive disorder.

Grünblatt E, Oneda B, Ekici AB, Ball J, Geissler J, Uebe S, Romanos M, Rauch A, Walitza S.

BMC Med Genomics. 2017 Nov 28;10(1):68. doi: 10.1186/s12920-017-0299-5.

8.

Progress in genome-wide association studies of schizophrenia in Han Chinese populations.

Yue W, Yu X, Zhang D.

NPJ Schizophr. 2017 Aug 10;3(1):24. doi: 10.1038/s41537-017-0029-1. Review.

9.

Conditional Deletion of All Neurexins Defines Diversity of Essential Synaptic Organizer Functions for Neurexins.

Chen LY, Jiang M, Zhang B, Gokce O, Südhof TC.

Neuron. 2017 May 3;94(3):611-625.e4. doi: 10.1016/j.neuron.2017.04.011.

10.

Genetic predictors of antipsychotic response to lurasidone identified in a genome wide association study and by schizophrenia risk genes.

Li J, Yoshikawa A, Brennan MD, Ramsey TL, Meltzer HY.

Schizophr Res. 2018 Feb;192:194-204. doi: 10.1016/j.schres.2017.04.009. Epub 2017 Apr 19.

PMID:
28431800
11.

Association study between the neurexin-1 gene and tardive dyskinesia.

Lanning R, Lett TA, Tiwari AK, Brandl EJ, de Luca V, Voineskos AN, Potkin SG, Lieberman JA, Meltzer HY, Müller DJ, Remington G, Kennedy JL, Zai CC.

Hum Psychopharmacol. 2017 Jan;32(1). doi: 10.1002/hup.2568.

PMID:
28120489
12.

Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects.

Marshall CR, Howrigan DP, Merico D, Thiruvahindrapuram B, Wu W, Greer DS, Antaki D, Shetty A, Holmans PA, Pinto D, Gujral M, Brandler WM, Malhotra D, Wang Z, Fajarado KVF, Maile MS, Ripke S, Agartz I, Albus M, Alexander M, Amin F, Atkins J, Bacanu SA, Belliveau RA Jr, Bergen SE, Bertalan M, Bevilacqua E, Bigdeli TB, Black DW, Bruggeman R, Buccola NG, Buckner RL, Bulik-Sullivan B, Byerley W, Cahn W, Cai G, Cairns MJ, Campion D, Cantor RM, Carr VJ, Carrera N, Catts SV, Chambert KD, Cheng W, Cloninger CR, Cohen D, Cormican P, Craddock N, Crespo-Facorro B, Crowley JJ, Curtis D, Davidson M, Davis KL, Degenhardt F, Del Favero J, DeLisi LE, Dikeos D, Dinan T, Djurovic S, Donohoe G, Drapeau E, Duan J, Dudbridge F, Eichhammer P, Eriksson J, Escott-Price V, Essioux L, Fanous AH, Farh KH, Farrell MS, Frank J, Franke L, Freedman R, Freimer NB, Friedman JI, Forstner AJ, Fromer M, Genovese G, Georgieva L, Gershon ES, Giegling I, Giusti-Rodríguez P, Godard S, Goldstein JI, Gratten J, de Haan L, Hamshere ML, Hansen M, Hansen T, Haroutunian V, Hartmann AM, Henskens FA, Herms S, Hirschhorn JN, Hoffmann P, Hofman A, Huang H, Ikeda M, Joa I, Kähler AK, Kahn RS, Kalaydjieva L, Karjalainen J, Kavanagh D, Keller MC, Kelly BJ, Kennedy JL, Kim Y, Knowles JA, Konte B, Laurent C, Lee P, Lee SH, Legge SE, Lerer B, Levy DL, Liang KY, Lieberman J, Lönnqvist J, Loughland CM, Magnusson PKE, Maher BS, Maier W, Mallet J, Mattheisen M, Mattingsdal M, McCarley RW, McDonald C, McIntosh AM, Meier S, Meijer CJ, Melle I, Mesholam-Gately RI, Metspalu A, Michie PT, Milani L, Milanova V, Mokrab Y, Morris DW, Müller-Myhsok B, Murphy KC, Murray RM, Myin-Germeys I, Nenadic I, Nertney DA, Nestadt G, Nicodemus KK, Nisenbaum L, Nordin A, O'Callaghan E, O'Dushlaine C, Oh SY, Olincy A, Olsen L, O'Neill FA, Van Os J, Pantelis C, Papadimitriou GN, Parkhomenko E, Pato MT, Paunio T; Psychosis Endophenotypes International Consortium, Perkins DO, Pers TH, Pietiläinen O, Pimm J, Pocklington AJ, Powell J, Price A, Pulver AE, Purcell SM, Quested D, Rasmussen HB, Reichenberg A, Reimers MA, Richards AL, Roffman JL, Roussos P, Ruderfer DM, Salomaa V, Sanders AR, Savitz A, Schall U, Schulze TG, Schwab SG, Scolnick EM, Scott RJ, Seidman LJ, Shi J, Silverman JM, Smoller JW, Söderman E, Spencer CCA, Stahl EA, Strengman E, Strohmaier J, Stroup TS, Suvisaari J, Svrakic DM, Szatkiewicz JP, Thirumalai S, Tooney PA, Veijola J, Visscher PM, Waddington J, Walsh D, Webb BT, Weiser M, Wildenauer DB, Williams NM, Williams S, Witt SH, Wolen AR, Wormley BK, Wray NR, Wu JQ, Zai CC, Adolfsson R, Andreassen OA, Blackwood DHR, Bramon E, Buxbaum JD, Cichon S, Collier DA, Corvin A, Daly MJ, Darvasi A, Domenici E, Esko T, Gejman PV, Gill M, Gurling H, Hultman CM, Iwata N, Jablensky AV, Jönsson EG, Kendler KS, Kirov G, Knight J, Levinson DF, Li QS, McCarroll SA, McQuillin A, Moran JL, Mowry BJ, Nöthen MM, Ophoff RA, Owen MJ, Palotie A, Pato CN, Petryshen TL, Posthuma D, Rietschel M, Riley BP, Rujescu D, Sklar P, St Clair D, Walters JTR, Werge T, Sullivan PF, O'Donovan MC, Scherer SW, Neale BM, Sebat J; CNV and Schizophrenia Working Groups of the Psychiatric Genomics Consortium.

Nat Genet. 2017 Jan;49(1):27-35. doi: 10.1038/ng.3725. Epub 2016 Nov 21. Erratum in: Nat Genet. 2017 Sep 27;49(10 ):1558. Nat Genet. 2017 Mar 30;49(4):651.

13.

Chromosomal microarray testing in adults with intellectual disability presenting with comorbid psychiatric disorders.

Wolfe K, Strydom A, Morrogh D, Carter J, Cutajar P, Eyeoyibo M, Hassiotis A, McCarthy J, Mukherjee R, Paschos D, Perumal N, Read S, Shankar R, Sharif S, Thirulokachandran S, Thygesen JH, Patch C, Ogilvie C, Flinter F, McQuillin A, Bass N.

Eur J Hum Genet. 2016 Jan;25(1):66-72. doi: 10.1038/ejhg.2016.107. Epub 2016 Sep 21.

14.

Genome-wide association study of serum coenzyme Q10 levels identifies susceptibility loci linked to neuronal diseases.

Degenhardt F, Niklowitz P, Szymczak S, Jacobs G, Lieb W, Menke T, Laudes M, Esko T, Weidinger S, Franke A, Döring F, Onur S.

Hum Mol Genet. 2016 Jul 1;25(13):2881-2891. Epub 2016 May 5.

PMID:
27149984
15.

Genome-wide Analysis of the Role of Copy Number Variation in Schizophrenia Risk in Chinese.

Li Z, Chen J, Xu Y, Yi Q, Ji W, Wang P, Shen J, Song Z, Wang M, Yang P, Wang Q, Feng G, Liu B, Sun W, Xu Q, Li B, He L, He G, Li W, Wen Z, Liu K, Huang F, Zhou J, Ji J, Li X, Shi Y.

Biol Psychiatry. 2016 Aug 15;80(4):331-337. doi: 10.1016/j.biopsych.2015.11.012. Epub 2015 Nov 26.

PMID:
26795442
16.

Heterozygous deletion of α-neurexin I or α-neurexin II results in behaviors relevant to autism and schizophrenia.

Dachtler J, Ivorra JL, Rowland TE, Lever C, Rodgers RJ, Clapcote SJ.

Behav Neurosci. 2015 Dec;129(6):765-76. doi: 10.1037/bne0000108.

17.

Two rare deletions upstream of the NRXN1 gene (2p16.3) affecting the non-coding mRNA AK127244 segregate with diverse psychopathological phenotypes in a family.

Duong LT, Hoeffding LK, Petersen KB, Knudsen CD, Thygesen JH, Klitten LL, Tommerup N, Ingason A, Werge T.

Eur J Med Genet. 2015 Dec;58(12):650-3. doi: 10.1016/j.ejmg.2015.11.004. Epub 2015 Nov 10.

PMID:
26563496
18.

A de novo microdeletion in NRXN1 in a Dutch patient with mild intellectual disability, microcephaly and gonadal dysgenesis.

Agha Z, Iqbal Z, Kleefstra T, Zweier C, Pfundt R, Qamar R, VAN Bokhoven H, Willemsen MH.

Genet Res (Camb). 2015 Oct 6;97:e19. doi: 10.1017/S001667231500021X.

PMID:
26438105
19.

[The Role of Neurotrophins and Neurexins Genes in the Risk of Paranoid Schizophrenia in Russians and Tatars].

Gareeva AE, Traks T, Koks S, Khusnutdinova EK.

Genetika. 2015 Jul;51(7):799-811. Russian.

PMID:
26410934
20.

Human Neuropsychiatric Disease Modeling using Conditional Deletion Reveals Synaptic Transmission Defects Caused by Heterozygous Mutations in NRXN1.

Pak C, Danko T, Zhang Y, Aoto J, Anderson G, Maxeiner S, Yi F, Wernig M, Südhof TC.

Cell Stem Cell. 2015 Sep 3;17(3):316-28. doi: 10.1016/j.stem.2015.07.017. Epub 2015 Aug 13.

Supplemental Content

Loading ...
Support Center